PCSK1N作为促肾上腺皮质激素细胞垂体腺瘤的肿瘤大小标志物和内质网应激反应蛋白
研究比较33例功能性促肾上腺皮质激素腺瘤(FCA)与18例静止性促肾上腺皮质激素腺瘤(SCA)中PCSK1N的表达,并在AtT-20细胞中诱导内质网应激。结果发现SCA中PCSK1N表达高于FCA,且与肿瘤最大直径相关;PCSK1N可能参与内质网应激适应性反应。
要点
- SCA中PCSK1N表达高于FCA,且与POMC、TPIT、PCSK1表达及肿瘤最大直径相关。
- 17-AAG诱导AtT-20细胞内质网应激后,Pomc表达下降而Pcsk1n表达升高。
- PCSK1N可能是内质网应激适应性反应的一部分,可能与其他蛋白共同赋予细胞生存优势。
核心结论
- PCSK1N在SCA中高于FCA,与促肾上腺皮质激素细胞标志物及肿瘤大小相关。
- PCSK1N可能是内质网应激适应性反应的一部分,可能与其他蛋白共同赋予促肾上腺皮质激素肿瘤细胞生存优势。
研究设计与样本
- 记录33例FCA(20例女性,11例大腺瘤)和18例SCA(8例女性,均为大腺瘤)的临床和影像学特征。
- 用逆转录定量聚合酶链反应检测腺瘤组织中POMC、TBX19/TPIT、PCSK1/PC1/3及其抑制剂PCSK1N的基因表达。
- 用HSP90伴侣抑制剂tanespimycin(17-AAG)处理小鼠垂体促肾上腺皮质激素肿瘤(AtT-20)细胞以诱导内质网应激,随后进行基因和蛋白分析。
主要发现
- FCA中POMC、TPIT和PCSK1表达高于SCA,而PCSK1N表达低于SCA。
- 在所有CA中,PCSK1N与POMC相关(rs = -0.514;P < .001),与TPIT相关(rs = -0.386;P = .005),与PCSK1相关(rs = -0.3691;P = .008),与肿瘤最大直径相关(rs = 0.645;P < .001)。
- 17-AAG诱导AtT-20细胞内质网应激后24小时,Pomc基因表达下降而Pcsk1n基因表达升高。
- 蛋白水平观察到细胞周期、凋亡和衰老通路下调,以及细胞黏附和细胞骨架的改变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Silent corticotroph adenoma (SCA) exhibits more tumor aggressiveness features than functioning adenomas (FCAs). OBJECTIVE: We aimed to investigate proprotein convertase subtilisin/kexin type 1 inhibitor (PCSK1N) expression in CA and examine if endoplasmic reticulum (ER) stress-induced responses affect cell survival in a corticotroph tumor cell model. METHODS: Clinical and imaging characteristics were recorded in 33 patients with FCA (20 women, 11 macroadenomas) and 18 SCAs (8 women, all macroadenomas). Gene expression of pro-opiomelanocortin (POMC), T-box transcription factor 19(TBX19)/TPIT, proprotein convertase subtilisin/kexin type 1 (PCSK1)/PC1/3, and its inhibitor PCSK1N, was measured by reverse transcription-quantitative polymerase chain reaction in adenoma tissue. Mouse pituitary corticotroph tumor (AtT-20) cells were treated with tanespimycin (17-AAG), an HSP90 chaperone inhibitor, to induce ER stress, followed by gene and protein analyses. RESULTS: POMC, TPIT, and PCSK1 expression were higher, whereas PCSK1N was lower in FCA compared to SCA. PCSK1N correlated with POMC (rs = -0.514; P < .001), TPIT (rs = -0.386; P = .005), PCSK1 (rs = -0.3691; P = .008), and tumor largest diameter (rs = 0.645; P < .001), in all CA. Induction of ER stress by 17-AAG in AtT-20 cells led to a decrease of Pomc and an increase of Pcsk1n gene expression at 24 hours. Moreover, a downregulation of cell cycle, apoptosis, and senescence pathways, and alterations in cell adhesion and cytoskeleton, were observed at the protein level. CONCLUSION: PCSK1N is higher in SCA compared with FCA, and associated with corticotroph cell markers and tumor size. PCSK1N is likely to be part of the adaptive response to ER stress, potentially conferring a survival advantage to the corticotroph tumor cell in conjunction with other proteins.
引用
- Abusdal M, Normann KR, Nyman TA, et al. PCSK1N as a Tumor Size Marker and an ER Stress Response Protein in Corticotroph Pituitary Adenomas. J Clin Endocrinol Metab. 2025. PMID: 39288010. doi:10.1210/clinem/dgae643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。